Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Finasteride improves hair growth.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

The patient was diagnosed with anorexia nervosa and severe malnutrition, requiring urgent refeeding and monitoring.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Trichoscopy helps quickly identify autoimmune diseases on the scalp but should be used with other standard tests.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Dermatologists should understand cultural practices and communicate empathetically to effectively treat skin conditions in children and teens of color.

Pregnancy with Cushing's syndrome is rare and risky for both mother and baby, needing early diagnosis and treatment.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Doctors should use a detailed patient history and physical exam to diagnose joint pain, and consult a rheumatologist early for suspected autoimmune diseases.

Skin health and diseases are closely linked to metabolic processes.

Indian men have 62.1% hair loss, mostly grade II vertex, and less extensive than other populations.

Lichen planopilaris is the most common type of scarring hair loss observed, with a variety of symptoms and tissue changes.

Diagnosing and managing PCOS in teens is hard, but early diagnosis and lifestyle changes are key, and more research is needed for long-term health.

COVID-19 can cause or worsen skin issues.

HIV-infected men who have sex with men are at higher risk for aggressive syphilis, but treatment and tests are effective.

Scalp sarcoidosis can cause hair loss and needs accurate diagnosis and treatment with specific medications.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.